About

The baseline population rate of dizygotic twinning is approximately 1.1% per pregnancy, while monozygotic splitting remains constant near 0.4% regardless of maternal characteristics. Miscalculating your actual risk matters: underestimation leads to inadequate prenatal planning, insufficient caloric intake (twin pregnancies require roughly 40% more calories), and failure to arrange high-risk obstetric care. This calculator applies multiplicative relative risk modifiers for each independent factor - maternal age, family history of hyperovulation, BMI, parity, ethnicity, and ovulation-stimulating treatments - against the dizygotic base rate. The monozygotic component is added as a constant since it is not influenced by these variables. Results approximate population-level odds; individual physiology, particularly serum FSH concentration, introduces variance the model cannot capture.

Formulas

The total probability of conceiving twins in any given pregnancy is the sum of the monozygotic (identical) rate and the modified dizygotic (fraternal) rate:

P_twins = P_MZ + P_{DZ_base} × n∏i=1 RR_i

Where P_MZ = 0.004 (monozygotic constant), P_{DZ_base} = 0.011 (dizygotic base rate), and RR_i is the relative risk multiplier for factor i (age, ethnicity, BMI, parity, family history, fertility treatment, height, breastfeeding).

The result is expressed as a percentage, as odds ("1 in X"), and as a comparison to the population average. The odds conversion uses:

1 in X = 1P_twins

Where P_twins is expressed as a decimal fraction. The multiplier vs. average is simply P_twins0.015, since the combined global average twin rate is approximately 1.5%.

Reference Data

Risk Factor	Category / Value	Relative Risk (DZ)	Source / Notes
Maternal Age	18 - 24 years	0.80	Lower FSH baseline
Maternal Age	25 - 29 years	1.00	Reference group
Maternal Age	30 - 34 years	1.30	Rising FSH, peak hyperovulation
Maternal Age	35 - 39 years	1.70	Peak DZ twinning rate (Smits & Monden 2011)
Maternal Age	40+ years	1.50	Slight decline after peak
Family History (Maternal)	Mother is a DZ twin	2.50	Hyperovulation gene inheritance
Family History (Maternal)	Maternal grandmother had twins	1.70	Skipped generation possible
Family History (Paternal)	Father's side twins	1.00	No effect on ovulation
Ethnicity	West/Central African descent	1.80	Highest global DZ rate (~4.5%)
Ethnicity	European descent	1.00	Reference group
Ethnicity	Hispanic descent	0.90	Slightly below European baseline
Ethnicity	East Asian descent	0.55	Lowest global DZ rate (~0.6%)
Ethnicity	South Asian descent	0.80	Moderate reduction
BMI	≥ 30 kg/m²	1.40	Higher IGF-1 levels stimulate ovaries
BMI	25 - 29.9 kg/m²	1.20	Moderate elevation
BMI	18.5 - 24.9 kg/m²	1.00	Reference
BMI	< 18.5 kg/m²	0.70	Reduced ovulatory function
Parity	First pregnancy	1.00	Reference
Parity	2 - 3 prior births	1.30	Increasing parity raises DZ odds
Parity	4+ prior births	1.50	Grand multiparity effect
Previous Twin Pregnancy	Yes	3.50	Strong predictor of repeat DZ twinning
Fertility Treatment	Clomiphene citrate	5.00	~5 - 12% twin rate
Fertility Treatment	Gonadotropins (FSH/hMG)	9.00	~15 - 20% multiples
Fertility Treatment	IVF (single embryo transfer)	2.00	MZ splitting risk rises
Fertility Treatment	IVF (double embryo transfer)	12.00	~20 - 30% twins
Height	≥ 175 cm (5′ 9″)	1.30	Elevated IGF-1 association
Height	< 175 cm	1.00	Reference
Breastfeeding	Currently breastfeeding	1.50	Elevated prolactin may trigger double ovulation (Steinman 2006)

Frequently Asked Questions

Dizygotic twinning requires hyperovulation - the release of two ova in one cycle. This trait is governed by genes expressed in the mother. A father who carries the hyperovulation gene can pass it to his daughters, potentially making them more likely to have DZ twins, but he cannot cause his partner to hyperovulate. Therefore, paternal family history has a relative risk of 1.00 (no effect) on the current pregnancy.

With double embryo transfer (DET), two embryos are placed in the uterus. The twin rate from DET ranges from 20 to 30% depending on embryo quality and maternal age. Compared to the natural DZ base rate of 1.1%, this represents roughly a 12× increase. Single embryo transfer (SET) still carries about 2× risk because the manipulation process slightly increases monozygotic splitting.

The association is considered causal via the IGF-1 (insulin-like growth factor 1) pathway. Women with BMI ≥ 30 kg/m² have elevated IGF-1, which stimulates ovarian follicle development and increases the likelihood of releasing multiple ova. The Reddy et al. (2005) study controlled for age, parity, and ethnicity and still found an adjusted odds ratio of approximately 1.4 for obese vs. normal-weight women.

DZ twinning peaks between ages 35 and 39 (relative risk 1.70). This occurs because FSH (follicle-stimulating hormone) levels rise with age as the ovaries require more stimulation, occasionally triggering double ovulation. After 40, overall fertility drops sharply. Fewer viable follicles remain, so despite high FSH, the likelihood of two successful ovulations decreases. The RR drops to approximately 1.50.

No. Monozygotic twinning is modeled as a constant (0.4%) because no reliable maternal risk factor modifies it in natural conception. The exception is IVF, where embryo manipulation may slightly increase MZ splitting. This calculator adds the MZ constant to the modified DZ rate but does not break out MZ probability as a separately adjustable component.

Lactational amenorrhea does suppress ovulation in many women, but those who do ovulate while breastfeeding have elevated prolactin and IGF-1 levels. Steinman (2006) found that women who conceived while breastfeeding had a DZ twinning rate approximately 1.5× higher than non-breastfeeding women. The paradox is selection bias: if you are ovulating despite breastfeeding, your hormonal profile already favors hyperovulation.